Author(s): Strausberg RL, Simpson AJ, Old LJ, Riggins GJ
Abstract Share this page
Abstract Scientists have sequenced the human genome and identified most of its genes. Now it is time to use these genomic data, and the high-throughput technology developed to generate them, to tackle major health problems such as cancer. To accelerate our understanding of this disease and to produce targeted therapies, further basic mutational and functional genomic information is required. A systematic and coordinated approach, with the results freely available, should speed up progress. This will best be accomplished through an international academic and pharmaceutical oncogenomics initiative.
This article was published in Nature
and referenced in Advances in Pharmacoepidemiology and Drug Safety